| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites
|
Cao, Jun
|
|
|
167 |
C |
p. 170-188
|
article
|
| 2 |
Antifibrotic strategies for medical devices
|
Welch, Nicholas G.
|
|
|
167 |
C |
p. 109-120
|
article
|
| 3 |
Clinically established biodegradable long acting injectables: An industry perspective
|
Nkanga, Christian Isalomboto
|
|
|
167 |
C |
p. 19-46
|
article
|
| 4 |
Correlation and clinical relevance of animal models for inhaled pharmaceuticals and biopharmaceuticals
|
Sécher, T.
|
|
|
167 |
C |
p. 148-169
|
article
|
| 5 |
Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy
|
Nakamura, Takashi
|
|
|
167 |
C |
p. 78-88
|
article
|
| 6 |
Editorial board members
|
|
|
|
167 |
C |
p. ii
|
article
|
| 7 |
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery
|
Finbloom, Joel A.
|
|
|
167 |
C |
p. 89-108
|
article
|
| 8 |
In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation
|
Newman, Stephen P.
|
|
|
167 |
C |
p. 135-147
|
article
|
| 9 |
Live long and active: Polypeptide-mediated assembly of antibody variable fragments
|
Lee, Changrim
|
|
|
167 |
C |
p. 1-18
|
article
|
| 10 |
Near-infrared fluorescence imaging in immunotherapy
|
Ji, Yuanyuan
|
|
|
167 |
C |
p. 121-134
|
article
|
| 11 |
Peptide and peptide-based inhibitors of SARS-CoV-2 entry
|
Schütz, Desiree
|
|
|
167 |
C |
p. 47-65
|
article
|
| 12 |
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
|
Sánchez-Félix, Manuel
|
|
|
167 |
C |
p. 66-77
|
article
|
Journal description